Mingzhi Zhang
Mingzhi Zhang
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| "Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL | extranodal nasal NK/T cell lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-07-14 | NCT06559553 | |
| A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma | Newly Diagnosed Diffuse Large B-cell Lymphoma | Recruiting | Phase 1 / Phase 2 | 2024-11-12 | NCT06683885 | |
| CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 1 | 2024-10-17 | NCT06647329 |